On behalf of the US Hemp Roundtable:  It happened later than we originally expected, but none-the-less the Farm Bill has officially been signed into law! Hemp and hemp derivatives are now permanently removed from regulation under the Controlled Substances Act! This is an historic moment, and we are happy to share it with all of our Hemp Supporters. In addition to developing the Roundtable's press release, our General Counsel Jonathan Miller also put together a summary of what the Farm Bill means for hemp and hosted a Facebook Live session with Hemp Supporters today for a surprise Q&A session. It’s an exciting time for...

2018 Farm Bill Update By U.S. Hemp Roundtable | October 18, 2018 Here’s a report from Daniel Cameron of Frost Brown Todd, the Roundtable’s lead DC lobbyist and the former General Counsel to Senate Majority Leader Mitch McConnell. As the wheels of the legislative process continue to turn, the 2018 Farm Bill has confronted its share of potholes, primarily the result of disagreement on food stamp work requirements. Now, an external complication, Hurricane Michael, might push passage of the Farm Bill into early 2019. Per House Agriculture ranking member Collin Peterson, in the lame-duck session, after the November general election,...

WHAT IS CBD? Cannabidiol—CBD—is a cannabis compound that has significant medical benefits, but does not make people feel “stoned” and can actually counteract the psychoactivity of THC. The fact that CBD-rich cannabis is non-psychoactive or less psychoactive than THC-dominant strains makes it an appealing option for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and other conditions without disconcerting feelings of lethargy or dysphoria. Scientific and clinical research—much of it sponsored by the US government—underscores CBD’s potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United...

DEA takes some CBD off Schedule 1 – with FDA approval Published September 27, 2018 | By Hemp industry Daily staff 20.2k SHARES ShareTweetLinkedinRedditMail (This story has been updated to provide additional details from the DEA announcement.) The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval. The agency announced Thursday that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, as long as the medications have been approved...

In 1968, the Brown and Williamson Tobacco Company circulated an internal memo among colleagues where an executive of the company stated “What we want to do this morning is to take a summary look at the smoking and health question and then make a proposal to you for a B&W project to counter the anti-cigarette forces.” He continues “Doubt is our product, it is the best means of competing with the ‘body of fact’ that exists in the mind of the general public. It is also the means of establishing a controversy”. ( read the full memo here) Big tobacco...